首页|MicroRNA-141-5p/ABCG1逆转慢性粒细胞白血病K562细胞对伊马替尼的耐药性

MicroRNA-141-5p/ABCG1逆转慢性粒细胞白血病K562细胞对伊马替尼的耐药性

扫码查看
目的 探究miR-141-5p在慢性粒细胞白血病(CML)的作用机制及其对甲磺酸伊马替尼(IM)耐药性的影响。方法 qRT-PCR检测IM耐药和敏感患者miR-141-5p mRNA水平;Western blot法分别检测K562和K562/G01细胞转染前后MMP-3、MMP-9、Bcl-2等蛋白的表达情况;CCK-8检测K562和K562/G01细胞活性;荧光素酶实验检测miR-141-5p与ABCG1的结合情况;裸鼠成瘤验证miR-141-5p在体内对肿瘤的影响。结果 miR-141-5p在IM耐药的CML患者和K562/G01细胞中下调,且miR-141-5p的过表达可以抑制IM耐药CML细胞的生长并促进其凋亡。对荷瘤小鼠的研究表明,miR-141-5p在体内抑制肿瘤生长。miR-141-5p可以直接靶向作用于IM耐药CML细胞中的ABCG1调控CML发生。结论 miR-141-5p和ABCG1形成竞争性内源性RNA(ceRNA)网络,在IM耐药性中发挥作用,从而抑制CML的进展。
MicroRNA-141-5p/ABCG1 reverses imatinib resistance in K562 chronic myeloid leukemia cells
Objective To explore the mechanism of miR-141-5p and its effect on Imatinib(IM)resistance in CML.Methods qRT-PCR was used to detect miR-141-5p mRNA levels in IM resistant and sensitive patients.Western blot was used to detect the expression of proteins such as MMP-3,MMP-9,and Bcl-2 before and after transfection in K562 and K562/G01 cells.CCK-8 was used to detect of K562 and K562/G01 cell activity;Flow cytometry assay was used to detect the binding of miR-141-5p with ABCG1;Nude mice were used to validate the effect of miR-141-5p on tumors in vivo.Results The results showed that miR-141-5p was downregulated in IM-resistant CML patients and IM-resistant CML cells and overexpression of miR-141-5p could inhibit the growth of IM-resistant CML cells and promote their apoptosis.Research on tumor bearing mice had shown that miR-141-5p in-hibits tumor growth in vivo.Finally,it was found that miR-141-5p could directly target ABCG1 in IM-resistant CML cells to regulate CML occurrence.Conclusion miR-141-5p and ABCG1 form a competing endogenous RNA(ceRNA)network to function in IM resistance,thus facilitating CML progression.

chronic myeloid leukemiamiR-141-5pimatinibABCG1drug resistanceK562

许晗、许婷婷、汪万杰、鲍静

展开 >

安徽医科大学第一附属医院血液内科,合肥 230022

慢性粒细胞白血病 miR-141-5p 伊马替尼 ABCG1 耐药 K562

2024

安徽医科大学学报
安徽医科大学

安徽医科大学学报

CSTPCD北大核心
影响因子:1.095
ISSN:1000-1492
年,卷(期):2024.59(11)